Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
Edmond Teng, Carlo de Lena, Hélène Mollion, Kristin R. Wildsmith(Eisai (United States)), Terence J. O’Brien(The Royal Melbourne Hospital), Michael Dolton, Maria Carmela Tartaglia, Nawaf Yassi, Pierre Krolak‐Salmon, Oliver Peters, Reina N. Fuji, Timo Grimmer, Geoffrey A. Kerchner(Roche (Switzerland)), Pierre Anthony, Michael E. Ward(National Institutes of Health), Flávia Brunstein, Søren Nielsen, Karen Pickthorn, F. Vanhee, Ashwini Bobbala, Sandra E. Black(Sunnybrook Health Science Centre), A. Areovimata, Peter Farnbach, William Nisker, Chris Kyndt, Florence Pasquier(Centre Hospitalier Universitaire de Lille), Annette Justesen, Andrew Frank, Richard Bergeron(McGill University), Bali Toth, Monika Elisabeth Kottke-Arbeiter, Sietske A.M. Sikkes(Amsterdam Neuroscience), Vidya Ramakrishnan, Rik Vandenberghe(Allen Institute for Brain Science), Serge Belliard, Paul T. Manser, D Polívka, Christine A. F. Von Arnim(German Centre for Cardiovascular Research), Sandra Sanabria Bohórquez, Peter Alexandersen(Center for Clinical & Basic Research), Mira Blendstrup, Frédéric Blanc, Sharon Cohen, Mathieu Ceccaldi, Bruno Dubois(Portland State University), Raymond Schwartz, Siddhartha Lieten, Christoph Laske(University Children's Hospital Tübingen), Giuseppe Bruno
Cited by 188
Related Papers
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k